iSpecimen Inc.
ISPC
$1.55
-$0.04-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -2.63% | 201.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.63% | 201.16% | |||
| Cost of Revenue | -1.30% | -85.91% | |||
| Gross Profit | -4.05% | 113.09% | |||
| SG&A Expenses | -51.69% | 46.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -43.78% | -1.65% | |||
| Operating Income | 46.30% | 5.56% | |||
| Income Before Tax | 40.10% | 54.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.10% | 54.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.10% | 54.51% | |||
| EBIT | 46.30% | 5.56% | |||
| EBITDA | 46.34% | 3.31% | |||
| EPS Basic | 85.34% | 74.31% | |||
| Normalized Basic EPS | 85.34% | 74.31% | |||
| EPS Diluted | 85.34% | 74.31% | |||
| Normalized Diluted EPS | 85.34% | 74.31% | |||
| Average Basic Shares Outstanding | 308.47% | 77.07% | |||
| Average Diluted Shares Outstanding | 308.47% | 77.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||